ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sunlenca, Filmtabletten - 5
68386001 Gilead Sciences Switzerland Sàrl
Sunlenca, Filmtabletten07.07.2023
  07.07.2023
Lenacapavir (J05AX31) 
WHO-DDD06.07.2028
08.03.5
08.03. 
A  
Yes 
IPCI
3115.55Yes
    
10 %3404.75
  
7680683860011Synthetika
  
Composition
lenacapavirum 300 mg ut lenacapavirum natricum, copovidonum, poloxamerum 407, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 17.93 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Lenacapavirum300 mg
BAG: Active AgentDose
Lenacapavirum300 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
Copovidonum  
E 171 color.
E 172 color.
Macrogol3350  
Magnesii Stearas  
Mannitol  
Poloxamer407  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Talcum  
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home